John Plachetka has yet another reason to smile this week. On Thursday, Chapel Hill drug developer Pozen (Nasdaq: POZN) announced that it would pay its first-ever dividend to its shareholders, just a few days after the company broke free from a partnership with one drug company it didn’t like, and partnered with another company it does like...